JAMES D. BRISTOW, M. D.
Medical Practice at Parnassus Ave, San Francisco, CA

License number
California G59217
Category
Medical Practice
Type
Pediatrics
License number
California G59217
Category
Medical Practice
Type
Pediatric Cardiology
Address
Address
400 Parnassus Ave FLOOR 2ND, San Francisco, CA 94143
Phone
(415) 353-2008
(925) 296-5752 (Fax)

Professional information

James D Bristow Photo 1

Dr. James D Bristow, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Pediatric Cardiology
Address:
400 Parnassus Ave, San Francisco 94143
(415) 476-1040 (Phone)
UCSF Pediatric Heart Center
505 Parnassus Ave, San Francisco 94143
(415) 476-1040 (Phone)
Certifications:
Pediatric Cardiology, 1988, Pediatrics, 1986
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese, Spanish
Hospitals:
400 Parnassus Ave, San Francisco 94143
UCSF Pediatric Heart Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
Education:
Medical School
Harvard Medical School
Graduated: 1981
University Of California San Francisco
Graduated: 1982
Ssm Cardinal Glennon Children's Hospital
Graduated: 1984
St Louis Chldns Hospital
Graduated: 1986
Graduated: 1983
Graduated: 1988


James David Bristow Photo 2

James David Bristow, San Francisco CA

Specialties:
Pediatrics, Pediatric Cardiology, Thoracic Surgery, Cardiothoracic Vascular Surgery, Cardiology
Work:
UCSF Medical Center / Moffitt-Long Hospitals
400 Parnassus Ave, San Francisco, CA 94143
Education:
Harvard University(1981)


James Bristow Photo 3

Methods For Producing Proliferating Muscle Cells

US Patent:
2005026, Nov 24, 2005
Filed:
Mar 17, 2005
Appl. No.:
11/084591
Inventors:
Harold Bernstein - San Francisco CA, US
James Bristow - San Francisco CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K039/395, A61K048/00
US Classification:
424145100, 514044000
Abstract:
The present invention is related to compositions and methods for expanding cell populations suitable for use as cardiac or skeletal muscle grafts. In particular, the present invention provides methods for regulation of cell cycle withdrawal and myoblast fusion during myogenesis.